The global isothermal nucleic acid amplification technology market size is expected to reach USD 10,698.6 million by 2030, according to this report. The market is expected to expand at a CAGR of 12.3% from 2023 to 2030 A significant rise in awareness regarding the rapid testing and early detection of chronic and infectious diseases is expected to be a significant factor driving the market growth. Furthermore, the global growth in the prevalence of HIV, hepatitis, and sexually transmitted diseases, as well as the rise in adoption of INAAT for the diagnosis of such diseases, is anticipated to drive market growth. ![Global Isothermal Nucleic Acid Amplification Technology Market]( "Global Isothermal Nucleic Acid Amplification Technology Market")
INAAT offers a more sensitive, accurate, and rapid alternative to traditional methods, such as culture-based identification, for the diagnosis of infectious diseases. Similarly, INAAT techniques require minimal resources and are used without the need for thermal cyclers, which significantly improves the portability of such techniques. Moreover, isothermal amplification involves the use of less expensive procedures and equipment, which can fuel its adoption in developing countries. In particular, regions such as the Asia Pacific and Africa, that have recently witnessed epidemics of infectious diseases, such as Zika virus, tuberculosis, and influenza, present significant opportunities for market expansion.
To address the growing demand for INAAT offerings, key players are expanding their product portfolio by the launch of advanced reagents for the latest INAAT products. For instance, in March 2022, Thermo Fisher Scientific, Inc. launched its Invitrogen Super Script IV RT-LAMP Master Mix, intended for the detection of various viral pathogens. Such product launches are favoring market growth by increasing the utility of INAAT techniques for a broad range of applications.
Furthermore, COVID-19 has positively affected the market growth by increasing demand for the rapid and accurate testing alternatives used for the detection of the SARS-CoV-2 virus. Several key players have developed new INAAT-based COVID-19 testing products and have secured emergency use approvals for such products from the U.S. FDA. For instance, commercially available products in this domain include Grifols Diagnostic Solutions Inc.’s Procleix SARS-CoV-2 assay and Lucira Health, Inc.’s Lucira CHECK-IT COVID-19 test kit. Such strategic initiatives fueled by COVID-19 are likely to provide a significant stimulus to market growth in the near future.
INAAT offers a more sensitive, accurate, and rapid alternative to traditional methods, such as culture-based identification, for the diagnosis of infectious diseases. Similarly, INAAT techniques require minimal resources and are used without the need for thermal cyclers, which significantly improves the portability of such techniques. Moreover, isothermal amplification involves the use of less expensive procedures and equipment, which can fuel its adoption in developing countries. In particular, regions such as the Asia Pacific and Africa, that have recently witnessed epidemics of infectious diseases, such as Zika virus, tuberculosis, and influenza, present significant opportunities for market expansion.
To address the growing demand for INAAT offerings, key players are expanding their product portfolio by the launch of advanced reagents for the latest INAAT products. For instance, in March 2022, Thermo Fisher Scientific, Inc. launched its Invitrogen Super Script IV RT-LAMP Master Mix, intended for the detection of various viral pathogens. Such product launches are favoring market growth by increasing the utility of INAAT techniques for a broad range of applications.
Furthermore, COVID-19 has positively affected the market growth by increasing demand for the rapid and accurate testing alternatives used for the detection of the SARS-CoV-2 virus. Several key players have developed new INAAT-based COVID-19 testing products and have secured emergency use approvals for such products from the U.S. FDA. For instance, commercially available products in this domain include Grifols Diagnostic Solutions Inc.’s Procleix SARS-CoV-2 assay and Lucira Health, Inc.’s Lucira CHECK-IT COVID-19 test kit. Such strategic initiatives fueled by COVID-19 are likely to provide a significant stimulus to market growth in the near future.
Isothermal Nucleic Acid Amplification Technology Market Report Highlights
- By product, the reagents segment accounted for the largest market share in 2022 due to the widespread availability of thermo stable polymerases, and increasing demand for cost-effective diagnostic alternatives such as INAAT products
- Loop-mediated isothermal amplification (LAMP) technology accounted for the largest share of 16.10% in 2022 as the technique allows for the use of multiple modes of detection and has the ability to detect a broad range of RNA and DNA targets
- By application, infectious disease diagnostics held the largest share of 35.25% in 2022. This can be attributed to the rising prevalence of infectious disease, globally, and promising alternatives offered by INAAT technologies over PCR-based techniques
- North America held a share of 42.68% and dominated the global market in 2022, due to the rapid growth in the healthcare sector and the presence of key players such as Thermo Fisher Scientific, Inc., Quidel Corporation, Meridian Bioscience, Inc., and others within the region
- Hospitals end-use segment held the largest market share of 40.13% in 2022 due to the increasing adoption of INAAT techniques for rapid diagnostics and increasing global healthcare expenditure
Table of Contents
Chapter 1. Methodology And Scope
1.1 Market Segmentation And Scope
1.1.1 Segment Definitions
1.1.1.1 Test Segment
1.1.1.2 Service Provider Segment
1.1.1.3 Application Segment
1.2 Regional Scope
1.3 Estimates And Forecast Timeline
1.4 Objectives
1.4.1 Objective - 1
1.4.2 Objective - 2
1.4.3 Objective - 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 Gvr’s Internal Database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information Or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List Of Secondary Sources
1.11 List Of Abbreviations
1.1.1 Segment Definitions
1.1.1.1 Test Segment
1.1.1.2 Service Provider Segment
1.1.1.3 Application Segment
1.2 Regional Scope
1.3 Estimates And Forecast Timeline
1.4 Objectives
1.4.1 Objective - 1
1.4.2 Objective - 2
1.4.3 Objective - 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 Gvr’s Internal Database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information Or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List Of Secondary Sources
1.11 List Of Abbreviations
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation And Scope
3.2. Market Lineage Outlook
3.2.1 Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends And Outlook
3.4. Market Dynamics
3.4.1 Increasing Incidences Of Chronic Diseases And Rise In The Aging Population Across The Globe
3.4.2 Upsurge In The Molecular Diagnostics Market
3.4.3 Rise In Demand For Low Cost And Effective Diagnostics Procedures
3.4.4 Increase In The Available Disposable Income In The Developing Economies
3.4.5 Increase In The Adoption Of Inaat Over Pcr Is Boosting The Market
3.4.6 Rise In The Miniaturization Of Nucleic Acid-Based Diagnostics
3.5. Market Restraint Analysis
3.5.1 Stringent Regulatory Framework
3.5.2 Lack Of Awareness Over New Diagnostics Technologies
3.6. Business Environment Analysis
3.6.1. Swot Analysis; By Factor (Political & Legal, Economic And Technological)
3.6.2. Porter’s Five Forces Analysis
3.7. Covid-19 Impact Analysis
3.2. Market Lineage Outlook
3.2.1 Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends And Outlook
3.4. Market Dynamics
3.4.1 Increasing Incidences Of Chronic Diseases And Rise In The Aging Population Across The Globe
3.4.2 Upsurge In The Molecular Diagnostics Market
3.4.3 Rise In Demand For Low Cost And Effective Diagnostics Procedures
3.4.4 Increase In The Available Disposable Income In The Developing Economies
3.4.5 Increase In The Adoption Of Inaat Over Pcr Is Boosting The Market
3.4.6 Rise In The Miniaturization Of Nucleic Acid-Based Diagnostics
3.5. Market Restraint Analysis
3.5.1 Stringent Regulatory Framework
3.5.2 Lack Of Awareness Over New Diagnostics Technologies
3.6. Business Environment Analysis
3.6.1. Swot Analysis; By Factor (Political & Legal, Economic And Technological)
3.6.2. Porter’s Five Forces Analysis
3.7. Covid-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Isothermal Nucleic Acid Amplification Technology Market: Product Movement Analysis
4.2. Instruments
4.2.1 Instruments Market, 2018 - 2030 (USD Million)
4.3. Kits & Reagents
4.3.1 Kits & Reagents Market, 2018 - 2030 (USD Million)
4.2. Instruments
4.2.1 Instruments Market, 2018 - 2030 (USD Million)
4.3. Kits & Reagents
4.3.1 Kits & Reagents Market, 2018 - 2030 (USD Million)
Chapter 5. Technology Business Analysis
5.1. Isothermal Nucleic Acid Amplification Technology Market: Technology Movement Analysis
5.2. NASBA
5.2.1 NASBA Market, 2018 - 2030 (USD Million)
5.3. HDA
5.3.1 HDA Market, 2018 - 2030 (USD Million)
5.4. LA MP
5.4.1 LA MP Market, 2018 - 2030 (USD Million)
5.5. SDA
5.5.1 SDA Market, 2018 - 2030 (USD Million)
5.6. SPIA
5.6.1 SPIA Market, 2018 - 2030 (USD Million)
5.7. NEAR
5.7.1. NEAR Market, 2018 - 2030 (USD Million)
5.8. TMA
5.8.1. TMA Market, 2018 - 2030 (USD Million)
5.9. RCA
5.9.1 RCA Market, 2018 - 2030 (USD Million)
5.10. RPA
5.10.1 RPA Market, 2018 - 2030 (USD Million)
5.11. SMAP2
5.11.1 SMAP2 Market, 2018 - 2030 (USD Million)
5.12. Others
5.12.1. Others Market, 2018 - 2030 (USD Million)
5.2. NASBA
5.2.1 NASBA Market, 2018 - 2030 (USD Million)
5.3. HDA
5.3.1 HDA Market, 2018 - 2030 (USD Million)
5.4. LA MP
5.4.1 LA MP Market, 2018 - 2030 (USD Million)
5.5. SDA
5.5.1 SDA Market, 2018 - 2030 (USD Million)
5.6. SPIA
5.6.1 SPIA Market, 2018 - 2030 (USD Million)
5.7. NEAR
5.7.1. NEAR Market, 2018 - 2030 (USD Million)
5.8. TMA
5.8.1. TMA Market, 2018 - 2030 (USD Million)
5.9. RCA
5.9.1 RCA Market, 2018 - 2030 (USD Million)
5.10. RPA
5.10.1 RPA Market, 2018 - 2030 (USD Million)
5.11. SMAP2
5.11.1 SMAP2 Market, 2018 - 2030 (USD Million)
5.12. Others
5.12.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. Application Business Analysis
6.1. Isothermal Nucleic Acid Amplification Market: Application Movement Analysis
6.2. Blood Screening
6.2.1 Blood Screening Market, 2018 - 2030 (USD Million)
6.3. Infectious Disease Diagnosis
6.3.1 Infectious Disease Diagnosis Market, 2018 - 2030 (USD Million)
6.4. Cancer
6.4.1. Cancer Market, 2018 - 2030 (USD Million)
6.5. Others
6.5.1 Others Market, 2018 - 2030 (USD Million)
6.2. Blood Screening
6.2.1 Blood Screening Market, 2018 - 2030 (USD Million)
6.3. Infectious Disease Diagnosis
6.3.1 Infectious Disease Diagnosis Market, 2018 - 2030 (USD Million)
6.4. Cancer
6.4.1. Cancer Market, 2018 - 2030 (USD Million)
6.5. Others
6.5.1 Others Market, 2018 - 2030 (USD Million)
Chapter 7. End-Use Business Analysis
7.1. Isothermal Nucleic Acid Amplification Market: End-Use Movement Analysis
7.2. Hospital
7.2.1 Hospital Market, 2018 - 2030 (USD Million)
7.3. Central And Reference Laboratories
7.3.1 Central And Reference Laboratories Market, 2018 - 2030 (USD Million)
7.4. Others
7.4.1. Others Market, 2018 - 2030 (USD Million)
7.2. Hospital
7.2.1 Hospital Market, 2018 - 2030 (USD Million)
7.3. Central And Reference Laboratories
7.3.1 Central And Reference Laboratories Market, 2018 - 2030 (USD Million)
7.4. Others
7.4.1. Others Market, 2018 - 2030 (USD Million)
Chapter 8. Regional Business Analysis
8.1. Isothermal Nucleic Acid Amplification Technology Market: Regional Movement Analysis, 2022 & 2030
8.2. North America
8.2.1 North America Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.2.2 U.S.
8.2.1.1. Key Country Dynamics
8.2.1.2. Competitive Scenario
8.2.1.3. Prevalence Insights
8.2.1.4. Regulatory Framework
8.2.1.5. U.S. Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Key Country Dynamics
8.2.3.2 Competitive Scenario
8.2.3.3 Prevalence Insights
8.2.3.4 Regulatory Framework
8.2.3.5 Canada Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3. Europe
8.3.1 Europe Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.2 Uk
8.3.2.1 Key Country Dynamics
8.3.2.2 Competitive Scenario
8.3.2.3 Prevalence Insights
8.3.2.4 Regulatory Framework
8.3.2.5 Uk Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.3 Germany
8.3.3.1 Key Country Dynamics
8.3.3.2 Competitive Scenario
8.3.3.3 Prevalence Insights
8.3.3.4 Regulatory Framework
8.3.3.5 Germany Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.4 France
8.3.4.1 Key Country Dynamics
8.3.4.2 Competitive Scenario
8.3.4.3 Prevalence Insights
8.3.4.4 Regulatory Framework
8.3.4.5 France Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.5 Italy
8.3.5.1 Key Country Dynamics
8.3.5.2 Competitive Scenario
8.3.5.3 Prevalence Insights
8.3.5.4 Regulatory Framework
8.3.5.5 Italy Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.6 Spain
8.3.6.1 Key Country Dynamics
8.3.6.2 Competitive Scenario
8.3.6.3 Prevalence Insights
8.3.6.4 Regulatory Framework
8.3.6.5 Spain Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.7 Denmark
8.3.7.1 Key Country Dynamics
8.3.7.2 Competitive Scenario
8.3.7.3 Prevalence Insights
8.3.7.4 Regulatory Framework
8.3.7.5 Denmark Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.8 Sweden
8.3.8.1 Key Country Dynamics
8.3.8.2 Competitive Scenario
8.3.8.3 Prevalence Insights
8.3.8.4 Regulatory Framework
8.3.8.5 Sweden Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.9 Norway
8.3.9.1 Key Country Dynamics
8.3.9.2 Competitive Scenario
8.3.9.3 Prevalence Insights
8.3.9.4 Regulatory Framework
8.3.9.5 Norway Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4. Asia Pacific
8.4.1 Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.2 Japan
8.4.2.1 Key Country Dynamics
8.4.2.2 Competitive Scenario
8.4.2.3 Prevalence Insights
8.4.2.4 Regulatory Framework
8.4.2.5 Japan Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.3 China
8.4.3.1 Key Country Dynamics
8.4.3.2 Competitive Scenario
8.4.3.3 Prevalence Insights
8.4.3.4 Regulatory Framework
8.4.3.5 China Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.4 India
8.4.4.1 Key Country Dynamics
8.4.4.2 Competitive Scenario
8.4.4.3 Prevalence Insights
8.4.4.4 Regulatory Framework
8.4.4.5 India Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.5 Australia
8.4.5.1 Key Country Dynamics
8.4.5.2 Competitive Scenario
8.4.5.3 Prevalence Insights
8.4.5.4 Regulatory Framework
8.4.5.5 Australia Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.6 Thailand
8.4.6.1 Key Country Dynamics
8.4.6.2 Competitive Scenario
8.4.6.3 Prevalence Insights
8.4.6.4 Regulatory Framework
8.4.6.5 Thailand Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.7 South Korea
8.4.7.1 Key Country Dynamics
8.4.7.2 Competitive Scenario
8.4.7.3 Prevalence Insights
8.4.7.4 Regulatory Framework
8.4.7.5 South Korea Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5. Latin America
8.5.1 Latin America Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Key Country Dynamics
8.5.2.2 Competitive Scenario
8.5.2.3 Prevalence Insights
8.5.2.4 Regulatory Framework
8.5.2.5 Brazil Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.3 Mexico
8.5.3.1 Key Country Dynamics
8.5.3.2 Competitive Scenario
8.5.3.3 Prevalence Insights
8.5.3.4 Regulatory Framework
8.5.3.5 Mexico Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.4 Argentina
8.5.4.1 Key Country Dynamics
8.5.4.2 Competitive Scenario
8.5.4.3 Prevalence Insights
8.5.4.4 Regulatory Framework
8.5.4.5 Argentina Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6. Middle East & Africa
8.6.1 Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.2 South Africa
8.6.2.1 Key Country Dynamics
8.6.2.2 Competitive Scenario
8.6.2.3 Prevalence Insights
8.6.2.4 Regulatory Framework
8.6.2.5 South Africa Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Key Country Dynamics
8.6.3.2 Competitive Scenario
8.6.3.3 Prevalence Insights
8.6.3.4 Regulatory Framework
8.6.3.5 Saudi Arabia Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.4 UAE
8.6.4.1 Key Country Dynamics
8.6.4.2 Competitive Scenario
8.6.4.3 Prevalence Insights
8.6.4.4 Regulatory Framework
8.6.4.5 UAE Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.5 Kuwait
8.6.5.1 Key Country Dynamics
8.6.5.2 Competitive Scenario
8.6.5.3 Prevalence Insights
8.6.5.4 Regulatory Framework
8.6.5.5 Kuwait Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.2. North America
8.2.1 North America Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.2.2 U.S.
8.2.1.1. Key Country Dynamics
8.2.1.2. Competitive Scenario
8.2.1.3. Prevalence Insights
8.2.1.4. Regulatory Framework
8.2.1.5. U.S. Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Key Country Dynamics
8.2.3.2 Competitive Scenario
8.2.3.3 Prevalence Insights
8.2.3.4 Regulatory Framework
8.2.3.5 Canada Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3. Europe
8.3.1 Europe Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.2 Uk
8.3.2.1 Key Country Dynamics
8.3.2.2 Competitive Scenario
8.3.2.3 Prevalence Insights
8.3.2.4 Regulatory Framework
8.3.2.5 Uk Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.3 Germany
8.3.3.1 Key Country Dynamics
8.3.3.2 Competitive Scenario
8.3.3.3 Prevalence Insights
8.3.3.4 Regulatory Framework
8.3.3.5 Germany Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.4 France
8.3.4.1 Key Country Dynamics
8.3.4.2 Competitive Scenario
8.3.4.3 Prevalence Insights
8.3.4.4 Regulatory Framework
8.3.4.5 France Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.5 Italy
8.3.5.1 Key Country Dynamics
8.3.5.2 Competitive Scenario
8.3.5.3 Prevalence Insights
8.3.5.4 Regulatory Framework
8.3.5.5 Italy Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.6 Spain
8.3.6.1 Key Country Dynamics
8.3.6.2 Competitive Scenario
8.3.6.3 Prevalence Insights
8.3.6.4 Regulatory Framework
8.3.6.5 Spain Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.7 Denmark
8.3.7.1 Key Country Dynamics
8.3.7.2 Competitive Scenario
8.3.7.3 Prevalence Insights
8.3.7.4 Regulatory Framework
8.3.7.5 Denmark Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.8 Sweden
8.3.8.1 Key Country Dynamics
8.3.8.2 Competitive Scenario
8.3.8.3 Prevalence Insights
8.3.8.4 Regulatory Framework
8.3.8.5 Sweden Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.9 Norway
8.3.9.1 Key Country Dynamics
8.3.9.2 Competitive Scenario
8.3.9.3 Prevalence Insights
8.3.9.4 Regulatory Framework
8.3.9.5 Norway Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4. Asia Pacific
8.4.1 Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.2 Japan
8.4.2.1 Key Country Dynamics
8.4.2.2 Competitive Scenario
8.4.2.3 Prevalence Insights
8.4.2.4 Regulatory Framework
8.4.2.5 Japan Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.3 China
8.4.3.1 Key Country Dynamics
8.4.3.2 Competitive Scenario
8.4.3.3 Prevalence Insights
8.4.3.4 Regulatory Framework
8.4.3.5 China Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.4 India
8.4.4.1 Key Country Dynamics
8.4.4.2 Competitive Scenario
8.4.4.3 Prevalence Insights
8.4.4.4 Regulatory Framework
8.4.4.5 India Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.5 Australia
8.4.5.1 Key Country Dynamics
8.4.5.2 Competitive Scenario
8.4.5.3 Prevalence Insights
8.4.5.4 Regulatory Framework
8.4.5.5 Australia Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.6 Thailand
8.4.6.1 Key Country Dynamics
8.4.6.2 Competitive Scenario
8.4.6.3 Prevalence Insights
8.4.6.4 Regulatory Framework
8.4.6.5 Thailand Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.7 South Korea
8.4.7.1 Key Country Dynamics
8.4.7.2 Competitive Scenario
8.4.7.3 Prevalence Insights
8.4.7.4 Regulatory Framework
8.4.7.5 South Korea Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5. Latin America
8.5.1 Latin America Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Key Country Dynamics
8.5.2.2 Competitive Scenario
8.5.2.3 Prevalence Insights
8.5.2.4 Regulatory Framework
8.5.2.5 Brazil Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.3 Mexico
8.5.3.1 Key Country Dynamics
8.5.3.2 Competitive Scenario
8.5.3.3 Prevalence Insights
8.5.3.4 Regulatory Framework
8.5.3.5 Mexico Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.4 Argentina
8.5.4.1 Key Country Dynamics
8.5.4.2 Competitive Scenario
8.5.4.3 Prevalence Insights
8.5.4.4 Regulatory Framework
8.5.4.5 Argentina Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6. Middle East & Africa
8.6.1 Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.2 South Africa
8.6.2.1 Key Country Dynamics
8.6.2.2 Competitive Scenario
8.6.2.3 Prevalence Insights
8.6.2.4 Regulatory Framework
8.6.2.5 South Africa Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Key Country Dynamics
8.6.3.2 Competitive Scenario
8.6.3.3 Prevalence Insights
8.6.3.4 Regulatory Framework
8.6.3.5 Saudi Arabia Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.4 UAE
8.6.4.1 Key Country Dynamics
8.6.4.2 Competitive Scenario
8.6.4.3 Prevalence Insights
8.6.4.4 Regulatory Framework
8.6.4.5 UAE Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.5 Kuwait
8.6.5.1 Key Country Dynamics
8.6.5.2 Competitive Scenario
8.6.5.3 Prevalence Insights
8.6.5.4 Regulatory Framework
8.6.5.5 Kuwait Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.2.1 New Product Launch
9.2.2 Partnerships
9.2.3 Acquisition
9.2.4. Collaboration
9.2.5 Funding
9.3. Key Company Market Share Analysis, 2022
9.4. Company Profiles
9.4.1 Alere, Inc.
9.4.1.1 Company Overview
9.4.1.2 Financial Performance
9.4.1.3 Product Benchmarking
9.4.1.4 Strategic Initiatives
9.4.2 Biomerieux Sa
9.4.2.1 Company Overview
9.4.2.2 Financial Performance
9.4.2.3 Product Benchmarking
9.4.2.4 Strategic Initiatives
9.4.3 Eiken Chemical Co. Ltd
9.4.3.1 Company Overview
9.4.3.2 Financial Performance
9.4.3.3 Product Benchmarking
9.4.3.4 Strategic Initiatives
9.4.4 Hologic Inc.(Gen-Probe)
9.4.4.1 Company Overview
9.4.4.2 Financial Performance
9.4.4.3 Product Benchmarking
9.4.4.4 Strategic Initiatives
9.4.5 Lucigen
9.4.5.1 Company Overview
9.4.5.2 Financial Performance
9.4.5.3 Product Benchmarking
9.4.5.4 Strategic Initiatives
9.4.6 Meridian Bioscience, Inc.
9.4.6.1 Company Overview
9.4.6.2 Financial Performance
9.4.6.3 Product Benchmarking
9.4.6.4 Strategic Initiatives
9.4.7 Ustar Biotechnologies Ltd.
9.4.7.1 Company Overview
9.4.7.2 Financial Performance
9.4.7.3 Product Benchmarking
9.4.7.4 Strategic Initiatives
9.4.8 Qiagen
9.4.8.1 Company Overview
9.4.8.2 Financial Performance
9.4.8.3 Product Benchmarking
9.4.8.4 Strategic Initiatives
9.4.9 Quidel Corporation
9.4.9.1 Company Overview
9.4.9.2 Financial Performance
9.4.9.3 Product Benchmarking
9.4.9.4 Strategic Initiatives
9.4.10 Thermo Fisher Scientific, Inc.
9.4.10.1 Company Overview
9.4.10.2 Financial Performance
9.4.10.3 Product Benchmarking
9.4.10.4 Strategic Initiatives
9.4.11 Bd (Becton, Dickinson & Company)
9.4.11.1 Company Overview
9.4.11.2 Financial Performance
9.4.11.3 Product Benchmarking
9.4.11.4 Strategic Initiatives
9.4.12 Optigene Limited
9.4.12.1 Company Overview
9.4.12.2 Financial Performance
9.4.12.3 Product Benchmarking
9.4.12.4 Strategic Initiatives
9.2. Strategy Mapping
9.2.1 New Product Launch
9.2.2 Partnerships
9.2.3 Acquisition
9.2.4. Collaboration
9.2.5 Funding
9.3. Key Company Market Share Analysis, 2022
9.4. Company Profiles
9.4.1 Alere, Inc.
9.4.1.1 Company Overview
9.4.1.2 Financial Performance
9.4.1.3 Product Benchmarking
9.4.1.4 Strategic Initiatives
9.4.2 Biomerieux Sa
9.4.2.1 Company Overview
9.4.2.2 Financial Performance
9.4.2.3 Product Benchmarking
9.4.2.4 Strategic Initiatives
9.4.3 Eiken Chemical Co. Ltd
9.4.3.1 Company Overview
9.4.3.2 Financial Performance
9.4.3.3 Product Benchmarking
9.4.3.4 Strategic Initiatives
9.4.4 Hologic Inc.(Gen-Probe)
9.4.4.1 Company Overview
9.4.4.2 Financial Performance
9.4.4.3 Product Benchmarking
9.4.4.4 Strategic Initiatives
9.4.5 Lucigen
9.4.5.1 Company Overview
9.4.5.2 Financial Performance
9.4.5.3 Product Benchmarking
9.4.5.4 Strategic Initiatives
9.4.6 Meridian Bioscience, Inc.
9.4.6.1 Company Overview
9.4.6.2 Financial Performance
9.4.6.3 Product Benchmarking
9.4.6.4 Strategic Initiatives
9.4.7 Ustar Biotechnologies Ltd.
9.4.7.1 Company Overview
9.4.7.2 Financial Performance
9.4.7.3 Product Benchmarking
9.4.7.4 Strategic Initiatives
9.4.8 Qiagen
9.4.8.1 Company Overview
9.4.8.2 Financial Performance
9.4.8.3 Product Benchmarking
9.4.8.4 Strategic Initiatives
9.4.9 Quidel Corporation
9.4.9.1 Company Overview
9.4.9.2 Financial Performance
9.4.9.3 Product Benchmarking
9.4.9.4 Strategic Initiatives
9.4.10 Thermo Fisher Scientific, Inc.
9.4.10.1 Company Overview
9.4.10.2 Financial Performance
9.4.10.3 Product Benchmarking
9.4.10.4 Strategic Initiatives
9.4.11 Bd (Becton, Dickinson & Company)
9.4.11.1 Company Overview
9.4.11.2 Financial Performance
9.4.11.3 Product Benchmarking
9.4.11.4 Strategic Initiatives
9.4.12 Optigene Limited
9.4.12.1 Company Overview
9.4.12.2 Financial Performance
9.4.12.3 Product Benchmarking
9.4.12.4 Strategic Initiatives
List of Tables
Table 1: Global Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 2: Global Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 3: Global Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 4: Global Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 5: North America Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 6: North America Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 7: North America Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 8: North America Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 9: Europe Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 10: Europe Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 11: Europe Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 12: Europe Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 13: Asia Pacific Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 14: Asia Pacific Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 15: Asia Pacific Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 16: Asia Pacific Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 17: Latin America Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 18: Latin America Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 19: Latin America Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 20: Latin America Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 21: Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 22: Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 23: Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 24: Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 25: U.S. Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 26: U.S. Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 27: U.S. Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 28: U.S. Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 29: Canada Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 30: Canada Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 31: Canada Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 32: Canada Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 33: Germany Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 34: Germany Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 35: Germany Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 36: Germany Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 37: UK Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 38: UK Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 39: UK Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 40: UK Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 41: France Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 42: France Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 43: France Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 44: France Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 45: Spain Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 46: Spain Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 47: Spain Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 48: Spain Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 49: Sweden Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 50: Sweden Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 51: Sweden Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 52: Sweden Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 53: Denmark Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 54: Denmark Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 55: Denmark Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 56: Denmark Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 57: Norway Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 58: Norway Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 59: Norway Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 60: Norway Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 61: China Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 62: China Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 63: China Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 64: China Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 65: Japan Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 66: Japan Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 67: Japan Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 68: Japan Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 69: India Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 70: India Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 71: India Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 72: India Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 73: South Korea Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 74: South Korea Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 75: South Korea Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 76: South Korea Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 77: Australia Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 78: Australia Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 79: Australia Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 80: Australia Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 81: Thailand Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 82: Thailand Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 83: Thailand Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 84: Thailand Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 85: Brazil Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 86: Brazil Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 87: Brazil Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 88: Brazil Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 89: Mexico Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 90: Mexico Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 91: Mexico Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 92: Mexico Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 93: Argentina Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 94: Argentina Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 95: Argentina Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 96: Argentina Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 97: South Africa Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 98: South Africa Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 99: South Africa Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 100: South Africa Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 101: Saudi Arabia Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 102: Saudi Arabia Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 103: Saudi Arabia Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 104: Saudi Arabia Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 105: UAE Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 106: UAE Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 107: UAE Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 108: UAE Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 109: Kuwait Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 110: Kuwait Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 111: Kuwait Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 112: Kuwait Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 2: Global Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 3: Global Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 4: Global Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 5: North America Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 6: North America Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 7: North America Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 8: North America Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 9: Europe Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 10: Europe Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 11: Europe Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 12: Europe Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 13: Asia Pacific Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 14: Asia Pacific Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 15: Asia Pacific Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 16: Asia Pacific Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 17: Latin America Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 18: Latin America Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 19: Latin America Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 20: Latin America Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 21: Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 22: Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 23: Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 24: Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 25: U.S. Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 26: U.S. Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 27: U.S. Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 28: U.S. Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 29: Canada Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 30: Canada Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 31: Canada Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 32: Canada Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 33: Germany Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 34: Germany Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 35: Germany Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 36: Germany Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 37: UK Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 38: UK Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 39: UK Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 40: UK Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 41: France Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 42: France Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 43: France Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 44: France Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 45: Spain Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 46: Spain Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 47: Spain Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 48: Spain Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 49: Sweden Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 50: Sweden Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 51: Sweden Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 52: Sweden Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 53: Denmark Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 54: Denmark Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 55: Denmark Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 56: Denmark Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 57: Norway Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 58: Norway Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 59: Norway Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 60: Norway Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 61: China Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 62: China Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 63: China Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 64: China Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 65: Japan Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 66: Japan Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 67: Japan Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 68: Japan Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 69: India Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 70: India Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 71: India Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 72: India Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 73: South Korea Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 74: South Korea Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 75: South Korea Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 76: South Korea Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 77: Australia Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 78: Australia Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 79: Australia Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 80: Australia Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 81: Thailand Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 82: Thailand Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 83: Thailand Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 84: Thailand Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 85: Brazil Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 86: Brazil Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 87: Brazil Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 88: Brazil Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 89: Mexico Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 90: Mexico Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 91: Mexico Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 92: Mexico Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 93: Argentina Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 94: Argentina Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 95: Argentina Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 96: Argentina Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 97: South Africa Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 98: South Africa Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 99: South Africa Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 100: South Africa Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 101: Saudi Arabia Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 102: Saudi Arabia Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 103: Saudi Arabia Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 104: Saudi Arabia Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 105: UAE Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 106: UAE Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 107: UAE Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 108: UAE Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
Table 109: Kuwait Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018-2030 (USD Million)
Table 110: Kuwait Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018-2030 (USD Million)
Table 111: Kuwait Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018-2030 (USD Million)
Table 112: Kuwait Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018-2030 (USD Million)
List of Figures
Fig. 1: Market research process
Fig. 2: Information Procurement
Fig. 3: Primary Research Pattern
Fig. 4: Market Research Approaches
Fig. 5: Value Chain-Based Sizing & Forecasting
Fig. 6: Market Formulation & Validation
Fig. 7: Isothermal Nucleic Acid Amplification Technology Market Segmentation
Fig. 8: Market Driver Relevance Analysis (Current & Future Impact)
Fig. 9: Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 10: Penetration & Growth Prospect Mapping
Fig. 11: SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 12: Porter’s Five Forces Analysis
Fig. 13: Global Isothermal Nucleic Acid Amplification Technology Market, for Instruments, 2018-2030 (USD Million)
Fig. 14: Global Isothermal Nucleic Acid Amplification Technology Market, for Reagents, 2018-2030 (USD Million)
Fig. 15: Global Isothermal Nucleic Acid Amplification Technology Market, for NASBA, 2018-2030 (USD Million)
Fig. 16: Global Isothermal Nucleic Acid Amplification Technology Market, for HDA, 2018-2030 (USD Million)
Fig. 17: Global Isothermal Nucleic Acid Amplification Technology Market, for LAMP, 2018-2030 (USD Million)
Fig. 18: Global Isothermal Nucleic Acid Amplification Technology Market, for SDA, 2018-2030 (USD Million)
Fig. 19: Global Isothermal Nucleic Acid Amplification Technology Market, for SPIA, 2018-2030 (USD Million)
Fig. 20: Global Isothermal Nucleic Acid Amplification Technology Market, for NEAR, 2018-2030 (USD Million)
Fig. 21: Global Isothermal Nucleic Acid Amplification Technology Market, for TMA, 2018-2030 (USD Million)
Fig. 22: Global Isothermal Nucleic Acid Amplification Technology Market, for RCA, 2018-2030 (USD Million)
Fig. 23: Global Isothermal Nucleic Acid Amplification Technology Market, for RPA, 2018-2030 (USD Million)
Fig. 24: Global Isothermal Nucleic Acid Amplification Technology Market, for SMAP2, 2018-2030 (USD Million)
Fig. 25: Global Isothermal Nucleic Acid Amplification Technology Market, for Others, 2018-2030 (USD Million)
Fig. 26: Global Isothermal Nucleic Acid Amplification Technology Market, for Blood screening, 2018-2030 (USD Million)
Fig. 27: Global Isothermal Nucleic Acid Amplification Technology Market, for Infectious disease diagnostics, 2018-2030 (USD Million)
Fig. 28: Global Isothermal Nucleic Acid Amplification Technology Market, for Cancer, 2018-2030 (USD Million)
Fig. 29: Global Isothermal Nucleic Acid Amplification Technology Market, for Others, 2018-2030 (USD Million)
Fig. 30: Global Isothermal Nucleic Acid Amplification Technology Market, for Hospitals, 2018-2030 (USD Million)
Fig. 31: Global Isothermal Nucleic Acid Amplification Technology Market, for Central and reference labs, 2018-2030 (USD Million)
Fig. 32: Global Isothermal Nucleic Acid Amplification Technology Market, for Others, 2018-2030 (USD Million)
Fig. 33: Regional Marketplace: Key Takeaways
Fig. 34: Regional Outlook, 2021 & 2030
Fig. 35: North America Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 36: U.S. Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 37: Canada Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 38: Europe Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 39: Germany Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 40: UK Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 41: France Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 42: Spain Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 43: Italy Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 44: Sweden Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 45: Denmark Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 46: Norway Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 47: Asia Pacific Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 48: Japan Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 49: China Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 50: India Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 51: Australia Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 52: South Korea Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 53: Thailand Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 54: Latin America Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 55: Brazil Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 56: Mexico Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 57: Argentina Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 58: Middle East and Africa Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 59: South Africa Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 60: Saudi Arabia Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 61: UAE Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 62: Kuwait Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 2: Information Procurement
Fig. 3: Primary Research Pattern
Fig. 4: Market Research Approaches
Fig. 5: Value Chain-Based Sizing & Forecasting
Fig. 6: Market Formulation & Validation
Fig. 7: Isothermal Nucleic Acid Amplification Technology Market Segmentation
Fig. 8: Market Driver Relevance Analysis (Current & Future Impact)
Fig. 9: Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 10: Penetration & Growth Prospect Mapping
Fig. 11: SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 12: Porter’s Five Forces Analysis
Fig. 13: Global Isothermal Nucleic Acid Amplification Technology Market, for Instruments, 2018-2030 (USD Million)
Fig. 14: Global Isothermal Nucleic Acid Amplification Technology Market, for Reagents, 2018-2030 (USD Million)
Fig. 15: Global Isothermal Nucleic Acid Amplification Technology Market, for NASBA, 2018-2030 (USD Million)
Fig. 16: Global Isothermal Nucleic Acid Amplification Technology Market, for HDA, 2018-2030 (USD Million)
Fig. 17: Global Isothermal Nucleic Acid Amplification Technology Market, for LAMP, 2018-2030 (USD Million)
Fig. 18: Global Isothermal Nucleic Acid Amplification Technology Market, for SDA, 2018-2030 (USD Million)
Fig. 19: Global Isothermal Nucleic Acid Amplification Technology Market, for SPIA, 2018-2030 (USD Million)
Fig. 20: Global Isothermal Nucleic Acid Amplification Technology Market, for NEAR, 2018-2030 (USD Million)
Fig. 21: Global Isothermal Nucleic Acid Amplification Technology Market, for TMA, 2018-2030 (USD Million)
Fig. 22: Global Isothermal Nucleic Acid Amplification Technology Market, for RCA, 2018-2030 (USD Million)
Fig. 23: Global Isothermal Nucleic Acid Amplification Technology Market, for RPA, 2018-2030 (USD Million)
Fig. 24: Global Isothermal Nucleic Acid Amplification Technology Market, for SMAP2, 2018-2030 (USD Million)
Fig. 25: Global Isothermal Nucleic Acid Amplification Technology Market, for Others, 2018-2030 (USD Million)
Fig. 26: Global Isothermal Nucleic Acid Amplification Technology Market, for Blood screening, 2018-2030 (USD Million)
Fig. 27: Global Isothermal Nucleic Acid Amplification Technology Market, for Infectious disease diagnostics, 2018-2030 (USD Million)
Fig. 28: Global Isothermal Nucleic Acid Amplification Technology Market, for Cancer, 2018-2030 (USD Million)
Fig. 29: Global Isothermal Nucleic Acid Amplification Technology Market, for Others, 2018-2030 (USD Million)
Fig. 30: Global Isothermal Nucleic Acid Amplification Technology Market, for Hospitals, 2018-2030 (USD Million)
Fig. 31: Global Isothermal Nucleic Acid Amplification Technology Market, for Central and reference labs, 2018-2030 (USD Million)
Fig. 32: Global Isothermal Nucleic Acid Amplification Technology Market, for Others, 2018-2030 (USD Million)
Fig. 33: Regional Marketplace: Key Takeaways
Fig. 34: Regional Outlook, 2021 & 2030
Fig. 35: North America Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 36: U.S. Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 37: Canada Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 38: Europe Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 39: Germany Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 40: UK Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 41: France Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 42: Spain Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 43: Italy Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 44: Sweden Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 45: Denmark Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 46: Norway Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 47: Asia Pacific Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 48: Japan Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 49: China Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 50: India Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 51: Australia Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 52: South Korea Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 53: Thailand Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 54: Latin America Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 55: Brazil Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 56: Mexico Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 57: Argentina Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 58: Middle East and Africa Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 59: South Africa Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 60: Saudi Arabia Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 61: UAE Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Fig. 62: Kuwait Isothermal Nucleic Acid Amplification Technology Market, 2018-2030 (USD Million)
Companies Mentioned
- ALERE, INC.
- BIOMERIEUX SA
- EIKEN CHEMICAL CO. LTD
- HOLOGIC INC.(GEN-PROBE)
- LUCIGEN
- MERIDIAN BIOSCIENCE, INC.
- USTAR BIOTECHNOLOGIES LTD.
- QIAGEN
- QUIDEL CORPORATION
- THERMO FISHER SCIENTIFIC, INC.
- BD (BECTON, DICKINSON & COMPANY)
- OptiGene Limited
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Published | June 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 4235.34 Million |
| Forecasted Market Value ( USD | $ 10698.6 Million |
| Compound Annual Growth Rate | 12.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
